9559 related articles for article (PubMed ID: 2116998)
1. Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells.
Kohn EC; Francis EA; Liotta LA; Schiffmann E
Int J Cancer; 1990 Aug; 46(2):287-92. PubMed ID: 2116998
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factors stimulate chemotaxis in human melanoma cells.
Stracke ML; Kohn EC; Aznavoorian SA; Wilson LL; Salomon D; Krutzsch HC; Liotta LA; Schiffmann E
Biochem Biophys Res Commun; 1988 Jun; 153(3):1076-83. PubMed ID: 3291867
[TBL] [Abstract][Full Text] [Related]
3. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells.
Stracke ML; Engel JD; Wilson LW; Rechler MM; Liotta LA; Schiffmann E
J Biol Chem; 1989 Dec; 264(36):21544-9. PubMed ID: 2557332
[TBL] [Abstract][Full Text] [Related]
4. Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: human melanoma and ras-transfected NIH3T3 cells.
Seiki M; Sato H; Liotta LA; Schiffmann E
Int J Cancer; 1991 Nov; 49(5):717-20. PubMed ID: 1657797
[TBL] [Abstract][Full Text] [Related]
5. An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1.
Evans CP; Walsh DS; Kohn EC
Int J Cancer; 1991 Aug; 49(1):109-13. PubMed ID: 1874563
[TBL] [Abstract][Full Text] [Related]
6. Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells.
Kohn EC; Liotta LA; Schiffmann E
Biochem Biophys Res Commun; 1990 Jan; 166(2):757-64. PubMed ID: 2154219
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells.
Aznavoorian S; Stracke ML; Krutzsch H; Schiffmann E; Liotta LA
J Cell Biol; 1990 Apr; 110(4):1427-38. PubMed ID: 2324200
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration.
Kohn EC; Hollister GH; DiPersio JD; Wahl S; Liotta LA; Schiffmann E
Int J Cancer; 1993 Apr; 53(6):968-72. PubMed ID: 8473054
[TBL] [Abstract][Full Text] [Related]
9. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
10. Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells.
Stracke ML; Guirguis R; Liotta LA; Schiffmann E
Biochem Biophys Res Commun; 1987 Jul; 146(1):339-45. PubMed ID: 3496885
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of autocrine-motility-factor-like activity in oral squamous-cell-carcinoma cells.
Ishisaki A; Oida S; Momose F; Amagasa T; Rikimaru K; Ichijo H; Sasaki S
Int J Cancer; 1994 Dec; 59(6):783-8. PubMed ID: 7989119
[TBL] [Abstract][Full Text] [Related]
12. Evidence against roles for pertussis toxin sensitive G proteins or diacylglycerol generation in insulin-like growth factor-1 stimulated DNA synthesis in MG-63 osteosarcoma cells.
Linder B; Harris S; Eisen A; Nissley P
Mol Cell Endocrinol; 1994 Oct; 105(1):111-8. PubMed ID: 7821713
[TBL] [Abstract][Full Text] [Related]
13. Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
Timar J; Silletti S; Bazaz R; Raz A; Honn KV
Int J Cancer; 1993 Dec; 55(6):1003-10. PubMed ID: 8253518
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
[TBL] [Abstract][Full Text] [Related]
15. Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75.
Kleinman D; Roberts CT; LeRoith D; Schally AV; Levy J; Sharoni Y
Regul Pept; 1993 Oct; 48(1-2):91-8. PubMed ID: 8265821
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.
Neely EK; Rosenfeld RG
Endocrinology; 1992 Feb; 130(2):985-93. PubMed ID: 1370799
[TBL] [Abstract][Full Text] [Related]
17. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
Silletti S; Yao JP; Pienta KJ; Raz A
Int J Cancer; 1995 Sep; 63(1):100-5. PubMed ID: 7558435
[TBL] [Abstract][Full Text] [Related]
18. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
[TBL] [Abstract][Full Text] [Related]
19. The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts.
Furlanetto RW; DiCarlo JN; Wisehart C
J Clin Endocrinol Metab; 1987 Jun; 64(6):1142-9. PubMed ID: 2952664
[TBL] [Abstract][Full Text] [Related]
20. Tumor cell autocrine motility factor.
Liotta LA; Mandler R; Murano G; Katz DA; Gordon RK; Chiang PK; Schiffmann E
Proc Natl Acad Sci U S A; 1986 May; 83(10):3302-6. PubMed ID: 3085086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
